[HTML][HTML] Erlotinib after failure of gefitinib in patients with advanced non-small cell lung cancer previously responding to gefitinib
Background Gefitinib and erlotinib are two orally active epidermal growth factor receptor
tyrosine kinase inhibitors used in the treatment of advanced non-small cell lung cancer …
tyrosine kinase inhibitors used in the treatment of advanced non-small cell lung cancer …
[PDF][PDF] Erlotinib after Failure of Gefitinib in Patients with Advanced Non-small Cell Lung Cancer Previously Responding to Gefitinib
E Vasile, C Tibaldi, A Chella, A Falcone - Journal of Thoracic Oncology, 2008 - core.ac.uk
Background: Gefitinib and erlotinib are two orally active epidermal growth factor receptor
tyrosine kinase inhibitors used in the treatment of advanced non-small cell lung cancer …
tyrosine kinase inhibitors used in the treatment of advanced non-small cell lung cancer …
[PDF][PDF] Erlotinib after Failure of Gefitinib in Patients with Advanced Non-small Cell Lung Cancer Previously Responding to Gefitinib
E Vasile, C Tibaldi, A Chella… - Journal of Thoracic …, 2008 - scholar.archive.org
Background: Gefitinib and erlotinib are two orally active epidermal growth factor receptor
tyrosine kinase inhibitors used in the treatment of advanced non-small cell lung cancer …
tyrosine kinase inhibitors used in the treatment of advanced non-small cell lung cancer …
[引用][C] Erlotinib after Failure of Gefitinib in Patients with Advanced Non-small Cell Lung Cancer Previously Responding to Gefitinib
E Vasile, C Tibaldi, A Chella, A Falcone - Journal of Thoracic Oncology, 2008 - cir.nii.ac.jp
Erlotinib after Failure of Gefitinib in Patients with Advanced Non-small Cell Lung Cancer
Previously Responding to Gefitinib | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Previously Responding to Gefitinib | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Erlotinib after failure of gefitinib in patients with advanced non-small cell lung cancer previously responding to gefitinib.
E Vasile, C Tibaldi, A Chella… - Journal of Thoracic …, 2008 - europepmc.org
Background Gefitinib and erlotinib are two orally active epidermal growth factor receptor
tyrosine kinase inhibitors used in the treatment of advanced non-small cell lung cancer …
tyrosine kinase inhibitors used in the treatment of advanced non-small cell lung cancer …
[引用][C] Erlotinib after failure of gefitinib in patients with advanced non-small cell lung cancer previously responding to gefitinib
E Vasile, C Tibaldi, A Chella, A Falcone - JOURNAL OF THORACIC …, 2008 - arpi.unipi.it
Erlotinib after failure of gefitinib in patients with advanced non-small cell lung cancer
previously responding to gefitinib IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore …
previously responding to gefitinib IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore …
Erlotinib after failure of gefitinib in patients with advanced non-small cell lung cancer previously responding to gefitinib
E Vasile, C Tibaldi, A Chella… - Journal of thoracic …, 2008 - pubmed.ncbi.nlm.nih.gov
Background Gefitinib and erlotinib are two orally active epidermal growth factor receptor
tyrosine kinase inhibitors used in the treatment of advanced non-small cell lung cancer …
tyrosine kinase inhibitors used in the treatment of advanced non-small cell lung cancer …
Erlotinib after Failure of Gefitinib in Patients with Advanced Non-small Cell Lung Cancer Previously Responding to Gefitinib
E Vasile, C Tibaldi, A Chella, A Falcone - Journal of Thoracic Oncology, 2008 - jto.org
Background Gefitinib and erlotinib are two orally active epidermal growth factor receptor
tyrosine kinase inhibitors used in the treatment of advanced non-small cell lung cancer …
tyrosine kinase inhibitors used in the treatment of advanced non-small cell lung cancer …